Aurobindo Pharma to meet investors with B&K Securities

Aurobindo Pharma Limited announced an investor meeting scheduled for December 18, 2025, between 04:00 PM and 05:00 PM IST. The meeting will be held in-person in Hyderabad and will involve representatives from B&K Securities. This engagement is part of the company's commitment to regularly communicate with the investor community.

The meeting aims to provide an opportunity for Aurobindo Pharma to present updates and address inquiries regarding the company's current and future prospects. The schedule and agenda are subject to change, with any modifications to be announced on the company's website.

Aurobindo Pharma has confirmed that no unpublished price sensitive information (UPSI) will be discussed during the interactions. Investors and stakeholders are encouraged to take note of the details. The intimation was digitally signed by Adi Reddy Baddigam on December 15, 2025.